NCT07476690

Brief Summary

Spasticity is a major contributor to functional limitations in children with cerebral palsy. Radial extracorporeal shock wave therapy (rESWT) has emerged as a non-invasive method for reducing spasticity; however, the optimal session frequency remains unclear. This randomized, assessor-blinded, parallel-group controlled trial investigates the effects of different rESWT session frequencies on spasticity, motor function, balance, pain, and muscle properties in children with cerebral palsy. Participants are randomly assigned to three groups receiving sham rESWT, one real rESWT session per week combined with sham, or two real rESWT sessions per week, in addition to routine neurological rehabilitation. Outcomes are assessed using clinical scales and ultrasonography-based measures, including shear wave elastography. The study aims to define the dose-response relationship of rESWT and inform optimal treatment protocols in pediatric neurorehabilitation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Nov 2025Jun 2026

Study Start

First participant enrolled

November 15, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2026

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Expected
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

February 10, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Cerebral PalsyExtracorporeal Shock Wave TherapyrESWTSession FrequencySpasticityMuscle StiffnessSonoelastographyPhysical FunctionBalancePediatric Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Modified Ashworth Scale Score for Ankle Plantarflexor Spasticity with Knee in Flexed and Extended Positions

    Ankle plantarflexor spasticity of the gastrocnemius-soleus complex in the most affected lower limb is assessed using the Modified Ashworth Scale (MAS) with the knee extended and flexed. The MAS is an ordinal scale ranging from 0 to 4 (including grade 1+): Grade 0: No increase in muscle tone. Grade 1: Slight increase in muscle tone with a catch and release or minimal resistance at the end of the range of motion. Grade 1+: Slight increase in muscle tone manifested by minimal resistance through less than half of the range of motion. Grade 2: More marked increase in muscle tone through most of the range of motion, but the affected part is easily moved. Grade 3: Considerable increase in muscle tone, making passive movement difficult. Grade 4: Affected part rigid in flexion or extension. Higher scores indicate greater spasticity severity.

    Baseline (pre-treatment), Day 1 post-treatment, Week 4 post-treatment, and Week 12 post-treatment

Secondary Outcomes (9)

  • Change from Baseline in Ankle Plantarflexor Spasticity Parameters Assessed by the Tardieu Scale with the Knee Extended and Flexed

    Baseline (pre-treatment), Day 1 post-treatment, Week 4 post-treatment, and Week 12 post-treatment

  • Change from Baseline in Passive Ankle Dorsiflexion Range of Motion with the Knee Extended and Flexed (Degrees)

    Baseline (pre-treatment), Day 1 post-treatment, Week 4 post-treatment, and Week 12 post-treatment

  • Change from Baseline in Pediatric Berg Balance Scale Score

    Baseline (pre-treatment), Day 1 post-treatment, Week 4 post-treatment, and Week 12 post-treatment

  • Change from Baseline in Modified Timed Up and Go Test Completion Time

    Baseline (pre-treatment), Day 1 post-treatment, Week 4 post-treatment, and Week 12 post-treatment

  • Change from Baseline in 10-Meter Walk Test Walking Speed

    Baseline (pre-treatment), Day 1 post-treatment, Week 4 post-treatment, and Week 12 post-treatment

  • +4 more secondary outcomes

Study Arms (3)

Control (Conventional Physical Therapy + Sham rESWT)

SHAM COMPARATOR

All participants continue routine neurological rehabilitation consisting of conventional physical therapy (60 minutes per session, 3 sessions per week for 12 weeks) tailored to individual goals. In this control arm, during the first 3 weeks, sham radial extracorporeal shock wave therapy (rESWT) is administered 2 days per week (total 6 sham sessions). Each session is followed by 20 minutes of stretching.

Device: Sham radial extracorporeal shock wave therapy (rESWT)Other: Conventional physical therapy

1 Real rESWT Session per Week (Real + Sham)

EXPERIMENTAL

All participants continue routine neurological rehabilitation consisting of conventional physical therapy (60 minutes per session, 3 sessions per week for 12 weeks) tailored to individual goals. During the first 3 weeks, rESWT is delivered 2 days per week using a hybrid schedule: one session per week of real rESWT and one session per week of sham rESWT (total 3 real and 3 sham sessions). Each session is followed by 20 minutes of stretching.

Device: Real radial extracorporeal shock wave therapy (rESWT)Device: Sham radial extracorporeal shock wave therapy (rESWT)Other: Conventional physical therapy

2 Real rESWT Sessions per Week (Real)

EXPERIMENTAL

All participants continue routine neurological rehabilitation consisting of conventional physical therapy (60 minutes per session, 3 sessions per week for 12 weeks) tailored to individual goals. During the first 3 weeks, real rESWT is administered 2 days per week (total 6 real sessions). Each session is followed by 20 minutes of stretching.

Device: Real radial extracorporeal shock wave therapy (rESWT)Other: Conventional physical therapy

Interventions

Real radial extracorporeal shock wave therapy is applied to spastic muscles using a radial shock wave device. Treatment is delivered during the first 3 weeks according to group allocation, with either one or two sessions per week. Each session is followed by 20 minutes of stretching.

1 Real rESWT Session per Week (Real + Sham)2 Real rESWT Sessions per Week (Real)

Sham radial extracorporeal shock wave therapy is administered using the same device and procedure as real rESWT but without therapeutic energy output. Sham treatment is delivered during the first 3 weeks according to group allocation.

1 Real rESWT Session per Week (Real + Sham)Control (Conventional Physical Therapy + Sham rESWT)

Routine neurological rehabilitation consisting of conventional physical therapy tailored to individual goals, provided for 60 minutes per session, 3 sessions per week for 12 weeks.

1 Real rESWT Session per Week (Real + Sham)2 Real rESWT Sessions per Week (Real)Control (Conventional Physical Therapy + Sham rESWT)

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 6-14 years diagnosed with cerebral palsy according to the Rosenbaum diagnostic criteria.
  • Gross Motor Function Classification System (GMFCS) level I, II, or III.
  • Modified Ashworth Scale (MAS) score \>1 and ≤3 in unilateral or bilateral ankle plantar flexor muscle groups.
  • Presence of a spastic gait pattern characterized by a dynamic component of ankle equinus.

You may not qualify if:

  • Age younger than 6 years or older than 14 years.
  • Botulinum toxin type A injection or extracorporeal shock wave therapy (ESWT) within 6 months prior to enrollment.
  • Fixed contracture with passive joint range of motion (ROM) \<5° in the affected extremity, or significant bone or joint deformity.
  • History of orthopedic surgery (tendon release or transfer, tenotomy, muscle release surgery, arthrodesis) involving the affected extremity.
  • Cognitive or behavioral disorders that would prevent participation in the intervention or assessments.
  • Uncontrolled systemic disease or significant comorbid conditions.
  • History of neurosurgical intervention (e.g., selective dorsal rhizotomy, neurectomy).
  • Presence of significant dystonia or severe movement disorder in the extremity to be evaluated.
  • Presence of contraindications for ESWT application in the treatment area, including open skin lesions, skin infection, signs of active inflammation, or history of malignancy; bleeding diathesis, use of anticoagulant therapy, or circulatory problems due to vascular pathology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sisli Hamidiye Etfal Training and Research Hospital

Istanbul, Istanbul, 34371, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • de Roo EG, Koopman SB, Janssen TW, Aertssen WFM. The effects of extracorporeal shock wave therapy in children with cerebral palsy: a systematic review. Int J Surg. 2025 Apr 1;111(4):2773-2790. doi: 10.1097/JS9.0000000000002251.

    PMID: 39878070BACKGROUND
  • Chang MC, Choo YJ, Kwak SG, Nam K, Kim SY, Lee HJ, Kwak S. Effectiveness of Extracorporeal Shockwave Therapy on Controlling Spasticity in Cerebral Palsy Patients: A Meta-Analysis of Timing of Outcome Measurement. Children (Basel). 2023 Feb 9;10(2):332. doi: 10.3390/children10020332.

    PMID: 36832460BACKGROUND
  • Kwon DR, Kwon DG. Botulinum Toxin a Injection Combined with Radial Extracorporeal Shock Wave Therapy in Children with Spastic Cerebral Palsy: Shear Wave Sonoelastographic Findings in the Medial Gastrocnemius Muscle, Preliminary Study. Children (Basel). 2021 Nov 17;8(11):1059. doi: 10.3390/children8111059.

    PMID: 34828772BACKGROUND

MeSH Terms

Conditions

Cerebral PalsyMuscle Spasticity

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Gülsüm Ertek Dutaç, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors are blinded to group allocation and to whether real or sham radial extracorporeal shock wave therapy (rESWT) is administered.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to three parallel groups receiving radial extracorporeal shock wave therapy (rESWT) with different session frequencies (real or sham), in addition to routine neurological rehabilitation. Participants remain in their assigned group throughout the study. The therapist delivering the intervention is not involved in outcome assessments.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 10, 2026

First Posted

March 17, 2026

Study Start

November 15, 2025

Primary Completion

March 1, 2026

Study Completion (Estimated)

June 15, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study involves pediatric patients and contains sensitive clinical and imaging data. Data are collected under local ethics committee approval and are intended to be used only for the predefined research objectives. To protect participant privacy and confidentiality, no individual-level data will be made publicly available.

Locations